Hemab Therapeutics Holdings, Inc.
COAG
$54.94
$0.991.84%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 457.46M | 163.53M | -- | ||
| Total Receivables | 1.82M | 1.43M | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 4.72M | 4.47M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 464.00M | 169.43M | -- | ||
|
|
|||||
| Total Current Assets | 464.00M | 169.43M | -- | ||
| Net Property, Plant & Equipment | 1.50M | 1.59M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 2.29M | 4.24M | -- | ||
| Total Assets | 467.78M | 175.26M | -- | ||
|
|
|||||
| Total Accounts Payable | 6.23M | 5.68M | -- | ||
| Total Accrued Expenses | 5.26M | 4.30M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 460.00K | 544.00K | -- | ||
| Total Finance Division Other Current Liabilities | 990.00K | 2.66M | -- | ||
| Total Other Current Liabilities | 990.00K | 2.66M | -- | ||
| Total Current Liabilities | 12.94M | 13.19M | -- | ||
|
|
|||||
| Total Current Liabilities | 12.94M | 13.19M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 566.00K | 519.00K | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | -- | ||
| Total Liabilities | 13.51M | 13.71M | -- | ||
|
|
|||||
| Common Stock & APIC | 685.71M | 6.37M | -- | ||
| Retained Earnings | -228.70M | -204.55M | -- | ||
| Treasury Stock & Other | -2.75M | -439.00K | -- | ||
| Total Common Equity | 454.27M | -198.62M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 360.17M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 360.17M | -- | ||
|
|
|||||
| Total Common Equity | 454.27M | -198.62M | -- | ||
| Total Preferred Equity | -- | 360.17M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 454.27M | 161.55M | -- | ||
|
|
|||||